Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor 1.
Brown
S M
SM
Lamberts
D W
DW
Reid
T W
TW
Nishida
T
T
Murphy
C J
CJ
D000287:Administration, Topical; D003315:Cornea / Q000187:drug effects / Q000294:innervation* / Q000473:pathology; D003316:Corneal Diseases / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007334:Insulin-Like Growth Factor I / Q000008:administration & dosage / Q000627:therapeutic use*; D015948:Keratoplasty, Penetrating; D009883:Ophthalmic Solutions; D013373:Substance P / Q000008:administration & dosage / Q000627:therapeutic use*; D013666:Tears / Q000378:metabolism; D014276:Trigeminal Nerve / Q000187:drug effects*
D009883:Ophthalmic Solutions; D013373:Substance P; D007334:Insulin-Like Growth Factor I